Bringing biology to life

Stately Bio is developing the next generation of life-saving regenerative medicines with the world's most advanced ML cell imaging platform.

Learn more

Rethinking how biology is measured

No more trade-off between measuring cells and keeping them alive. Our patented ML technology measures cell identity, behavior, and maturation—all directly from live-cell, label-free imaging.

See how it works

Discovering new
cell therapies

Using our technology as an engine of discovery, we are pioneering novel stem cell-derived therapies to usher in a new era of regenerative medicine.

Learn about our impact

Trusted by pioneers in cell therapy

We partner with top-tier institutions and companies to advance cell therapy innovation.

“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center

“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center
“This is a powerful new capability that fundamentally reshapes how one can approach cell therapy discovery and manufacturing. We are proud to work with Stately Bio on these important advancements.”
Larry Luchsinger, PhD
Chief Scientific Officer, New York Blood Center